Kateřina Nezvalová‐Henriksen

Author

Also Known As

Andreas Barratt-Due, K Nezvalova-Henriksen, K Nezvalová-Henriksen, K Nezvalová‐Henriksen, Katerina N. Henriksen, Katerina Nezvalova Henriksen, Katerina Nezvalova-Henriksen, Katerina Nezvalova‐Henriksen, Kateřina Nezvalová-Henriksen, Kateřina Nezvalová‐Henriksen

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

University of Oslo St Olav's University Hospital Norwegian University of Science and Technology Oslo University Hospital University Hospital of North Norway

About

Kateřina Nezvalová‐Henriksen is an author at University of Oslo specializing in medicine, women's health, and maternal health.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	130
2	Public Health	2	2	87
3	Critical Care Medicine	1	1	16
4	Immunology	1	1	12
5	Newborn Medicine	1	1	16

Kateřina Nezvalová‐Henriksen

Publications

781

Citations

H-Index

Page 1

	Year	Citations
Evaluation of the Effects of Remdesivir and Hydroxychloroquine on Viral Clearance in COVID-19 Andreas Barratt‐Due, Inge Christoffer Olsen, Kateřina Nezvalová‐Henriksen, Annals of Internal Medicine	2021	117
Triptan Exposure During Pregnancy and the Risk of Major Congenital Malformations and Adverse Pregnancy Outcomes: Results From The Norwegian Mother and Child Cohort Study Kateřina Nezvalová‐Henriksen, Olav Spigset, Hedvig Nordeng Headache The Journal of Head and Face Pain	2010	105
Effects of ibuprofen, diclofenac, naproxen, and piroxicam on the course of pregnancy and pregnancy outcome: a prospective cohort study Kateřina Nezvalová‐Henriksen, Olav Spigset, Hedvig Nordeng BJOG An International Journal of Obstetrics & Gynaecology	2013	98
Effects of codeine on pregnancy outcome: results from a large population-based cohort study Kateřina Nezvalová‐Henriksen, Olav Spigset, Hedvig Nordeng European Journal of Clinical Pharmacology	2011	96
Respiratory dysfunction three months after severe COVID‐19 is associated with gut microbiota alterations Beate Vestad, Thor Ueland, Tøri Vigeland Lerum, Journal of Internal Medicine	2022	81
Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial Marius Trøseid, José Ramón Arribas, Lambert Assoumou, Critical Care	2023	46
Triptan safety during pregnancy: a Norwegian population registry study Kateřina Nezvalová‐Henriksen, Olav Spigset, Hedvig Nordeng European Journal of Epidemiology Triptan SafetyMaternal ComplicationPatient SafetyPediatricsPregnancy	2013	45
Maternal Characteristics and Migraine Pharmacotherapy During Pregnancy: Cross-Sectional Analysis of Data from a Large Cohort Study Kateřina Nezvalová‐Henriksen, Olav Spigset, Hedvig Nordeng Cephalalgia Many WomenPain MedicineGynecologyHigh-risk PregnancyPrenatal Care	2009	42
Persistent pulmonary pathology after COVID-19 is associated with high viral load, weak antibody response, and high levels of matrix metalloproteinase-9 Tøri Vigeland Lerum, Niklas Maltzahn, Pål Aukrust, Scientific Reports	2021	37
High Circulating Levels of the Homeostatic Chemokines CCL19 and CCL21 Predict Mortality and Disease Severity in COVID-19 Anders Tveita, Sarah Louise Murphy, Jan Cato Holter, The Journal of Infectious Diseases	2022	21

Page 1